Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice

Ahn YH, Kim YH, Hong SH, Koh JY (1998) Depletion of intracellular zinc induces protein synthesis-dependent neuronal apoptosis in mouse cortical culture. Exp Neurol 154:47–56 Amin E, Pearce JM, Brown MW, Aggleton JP (2006) Novel temporal configurations of stimuli produce discrete changes in immediate-early gene expression in the rat hippocampus. Eur J Neurosci 24:2611–2621 Anand A, Shekhar A (2003) Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann N Y Acad Sci 985:370–388 Bhattacharya SK, Chakrabarti A, Chatterjee SS (1998) Activity profiles of two hyperforin-containing hypericum extracts in behavioral models. Pharmacopsychiatry 31(Suppl 1):22–29 Bodnoff SR, Suranyi-Cadotte B, Aitken DH, Quirion R, Meaney MJ (1988) The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl) 95:298–302 Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ (1989) A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berl) 97:277–279 Brown CE, Dyck RH (2004) Distribution of zincergic neurons in the mouse forebrain. J Comp Neurol 479:156–167 Butterweck V, Korte B, Winterhoff H (2001) Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment. Pharmacopsychiatry 34(Suppl 1):S2–S7 Caldarone BJ, Karthigeyan K, Harrist A, Hunsberger JG, Wittmack E, King SL, Jatlow P, Picciotto MR (2003) Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6 J mice. Psychopharmacology (Berl) 170:94–101 Chen N, Moshaver A, Raymond LA (1997) Differential sensitivity of recombinant N-methyl-d-aspartate receptor subtypes to zinc inhibition. Mol Pharmacol 51:1015–1023 Choi YB, Lipton SA (1999) Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor. Neuron 23:171–180 Chowanadisai W, Kelleher SL, Lonnerdal B (2005) Maternal zinc deficiency reduces NMDA receptor expression in neonatal rat brain, which persists into early adulthood. J Neurochem 94:510–519 Christine CW, Choi DW (1990) Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons. J Neurosci 10:108–116 Cryan JF, Holmes A (2005) The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4:775–790 D’Sa C, Duman RS (2002) Antidepressants and neuroplasticity. Bipolar Disord 4:183–194 Davidson RJ, Irwin W, Anderle MJ, Kalin NH (2003) The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 160:64–75 Dhir A, Kulkarni SK (2008) Possible involvement of nitric oxide (NO) signaling pathway in the antidepressant-like effect of MK-801(dizocilpine), a NMDA receptor antagonist in mouse forced swim test. Indian J Exp Biol 46:164–170 Drevets WC (2003) Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 985:420–444 Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF (2005) A double-blind, randomized trial of St John’s wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol 25:441–447 Flausino OA Jr, Zangrossi H Jr, Salgado JV, Viana MB (2002) Effects of acute and chronic treatment with Hypericum perforatum L. (LI 160) on different anxiety-related responses in rats. Pharmacol Biochem Behav 71:251–257 Frederickson CJ, Suh SW, Silva D, Frederickson CJ, Thompson RB (2000) Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 130:1471S–1483S Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J, Andrew CM, Pich EM, Williams PM, Reed LJ, Mitterschiffthaler MT, Suckling J, Bullmore ET (2004) Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61:877–889 Goodwin GM, Green AR, Johnson P (1984) 5-HT2 receptor characteristics in frontal cortex and 5-HT2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br J Pharmacol 83:235–242 Gordon JA, Hen R (2004) Genetic approaches to the study of anxiety. Annu Rev Neurosci 27:193–222 Greeson JM, Sanford B, Monti DA (2001) St. John’s wort (Hypericum perforatum) a review of the current pharmacological, toxicological, and clinical literature. Psychopharmacology (Berl) 153:402–414 Hansen CR Jr, Malecha M, Mackenzie TB, Kroll J (1983) Copper and zinc deficiencies in association with depression and neurological findings. Biol Psychiatry 18:395–401 Hefner K, Whittle N, Juhasz J, Norcross M, Karlsson RM, Saksida LM, Bussey TJ, Singewald N, Holmes A (2008) Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J Neurosci 28:8074–8085 Hosie AM, Dunne EL, Harvey RJ, Smart TG (2003) Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity. Nat Neurosci 6:362–369 Hypericum Depression Trial Study Group (2002) Effect of Hypericum perforatum (St John’s wort) in major depressive disorder: a randomized controlled trial. JAMA 287:1807–1814 Jenkins TA, Amin E, Brown MW, Aggleton JP (2006) Changes in immediate early gene expression in the rat brain after unilateral lesions of the hippocampus. Neuroscience 137:747–759 Jing MY, Sun JY, Wang JF (2008) The effect of peripheral administration of zinc on food intake in rats fed Zn-adequate or Zn-deficient diets. Biol Trace Elem Res 124:144–156 Kaehler ST, Sinner C, Chatterjee SS, Philippu A (1999) Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus. Neurosci Lett 262:199–202 Kalin NH, Davidson RJ, Irwin W, Warner G, Orendi JL, Sutton SK, Mock BJ, Sorenson JA, Lowe M, Turski PA (1997) Functional magnetic resonance imaging studies of emotional processing in normal and depressed patients: effects of venlafaxine. J Clin Psychiatry 58(Suppl 16):32–39 Knapska E, Kaczmarek L (2004) A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK? Prog Neurobiol 74:183–211 Kroczka B, Zieba A, Dudek D, Pilc A, Nowak G (2000) Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. Pol J Pharmacol 52:403–406 Kroczka B, Branski P, Palucha A, Pilc A, Nowak G (2001) Antidepressant-like properties of zinc in rodent forced swim test. Brain Res Bull 55:297–300 Kumar V, Mdzinarishvili A, Kiewert C, Abbruscato T, Bickel U, van der Schyf CJ, Klein J (2006) NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John’s Wort. J Pharmacol Sci 102:47–54 Kumar V, Singh PN, Bhattacharya SK (2001) Anti-stress activity of Indian Hypericum perforatum L. Indian J Exp Biol 39:344–349 Kwun IS, Cho YE, Lomeda RA, Kwon ST, Kim Y, Beattie JH (2007) Marginal zinc deficiency in rats decreases leptin expression independently of food intake and corticotrophin-releasing hormone in relation to food intake. Br J Nutr 98:485–489 Landgraf R, Wigger A (2002) High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety. Behav Genet 32:301–314 Langosch JM, Zhou XY, Heinen M, Kupferschmid S, Chatterjee SS, Noldner M, Walden J (2002) St John’s wort (Hypericum perforatum) modulates evoked potentials in guinea pig hippocampal slices via AMPA and GABA receptors. Eur Neuropsychopharmacol 12:209–216 Layer RT, Popik P, Olds T, Skolnick P (1995) Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol Biochem Behav 52:621–627 Lecrubier Y, Clerc G, Didi R, Kieser M (2002) Efficacy of St. John’s wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 159:1361–1366 Leonard BE (1997) Noradrenaline in basic models of depression. Eur Neuropsychopharmacol 7(Suppl 1):S11–S16 Discussion S71–3 Maes M, D’Haese PC, Scharpe S, D’Hondt P, Cosyns P, De Broe ME (1994) Hypozincemia in depression. J Affect Disord 31:135–140 McLoughlin IJ, Hodge JS (1990) Zinc in depressive disorder. Acta Psychiatr Scand 82:451–453 Mennini T, Gobbi M (2004) The antidepressant mechanism of Hypericum perforatum. Life Sci 75:1021–1027 Millan MJ (2006) Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110:135–370 Milton AL, Lee JL, Butler VJ, Gardner R, Everitt BJ (2008) Intra-amygdala and systemic antagonism of NMDA receptors prevents the reconsolidation of drug-associated memory and impairs subsequently both novel and previously acquired drug-seeking behaviors. J Neurosci 28:8230–8237 Moreno RA, Teng CT, Almeida KM, Tavares Junior H (2006) Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression: a randomized double-blind trial in a Brazilian sample. Rev Bras Psiquiatr 28:29–32 Muigg P, Hoelzl U, Palfrader K, Neumann I, Wigger A, Landgraf R, Singewald N (2007) Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biol Psychiatry 61:782–796 Murck H (2003) Atypical depression and related illnesses—neurobiological principles for their treatment with Hypericum extract. Acta Neuropsychiatrica 15:227–241 Nowak G, Szewczyk B, Pilc A (2005) Zinc and depression. An update. Pharmacol Rep 57:713–718 Padovan CM, Guimaraes FS (2004) Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats. Pharmacol Biochem Behav 77:15–19 Papakostas GI, Crawford CM, Scalia MJ, Fava M (2007) Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. A replication of findings with the use of a double-blind, placebo-controlled trial of Hypericum perforatum versus fluoxetine. Neuropsychobiology 56:132–137 Park EJ, Choi IS, Cho JH, Nakamura M, Lee JJ, Lee MG, Choi BJ, Moorhouse AJ, Jang IS (2008) Zinc modulation of glycine receptors in acutely isolated rat CA3 neurons. Life Sci 83(5–6):149–154 Parker G (2001) ‘New’ and ‘old’ antidepressants: all equal in the eyes of the lore? Br J Psychiatry 179:95–96 Paxinos KBJ, Franklin G (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press, London Poleszak E, Wlaz P, Wrobel A, Dybala M, Sowa M, Fidecka S, Pilc A, Nowak G (2007) Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test. Pharmacol Rep 59:595–600 Rachman IM, Unnerstall JR, Pfaff DW, Cohen RS (1998) Estrogen alters behavior and forebrain c-fos expression in ovariectomized rats subjected to the forced swim test. Proc Natl Acad Sci USA 95:13941–13946 Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939–1951 Rosa AO, Lin J, Calixto JB, Santos AR, Rodrigues AL (2003) Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 144:87–93 Ruiz A, Walker MC, Fabian-Fine R, Kullmann DM (2004) Endogenous zinc inhibits GABA(A) receptors in a hippocampal pathway. J Neurophysiol 91:1091–1096 Schulte T, Brecht S, Herdegen T, Illert M, Mehdorn HM, Hamel W (2006) Induction of immediate early gene expression by high-frequency stimulation of the subthalamic nucleus in rats. Neuroscience 138:1377–1385 Sernagor E, Kuhn D, Vyklicky L Jr, Mayer ML (1989) Open channel block of NMDA receptor responses evoked by tricyclic antidepressants. Neuron 2:1221–1227 Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U et al (2001) Effectiveness of St John’s wort in major depression: a randomized controlled trial. JAMA 285:1978–1986 Singewald N (2007) Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping. Neurosci Biobehav Rev 31:18–40 Singewald N, Sinner C, Hetzenauer A, Sartori SB, Murck H (2004) Magnesium-deficient diet alters depression- and anxiety-related behavior in mice—influence of desipramine and Hypericum perforatum extract. Neuropharmacology 47:1189–1197 Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367–370 Stewart CA, Reid IC (2002) Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission. Mol Psychiatry 7(Suppl 1):S15–S22 Surguladze S, Brammer MJ, Keedwell P, Giampietro V, Young AW, Travis MJ, Williams SC, Phillips ML et al (2005) A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry 57:201–209 Szasz BK, Mike A, Karoly R, Gerevich Z, Illes P, Vizi ES, Illes P, Vizi ES, Kiss JP (2007) Direct inhibitory effect of fluoxetine on N-methyl-d-aspartate receptors in the central nervous system. Biol Psychiatry 62:1303–1309 Szewczyk B, Branski P, Wieronska JM, Palucha A, Pilc A, Nowak G (2002) Interaction of zinc with antidepressants in the forced swimming test in mice. Pol J Pharmacol 54:681–685 Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185:1–10 Tschenett A, Singewald N, Carli M, Balducci C, Salchner P, Vezzani A, Herzog H, Sperk G (2003) Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 18:143–148 Vandenbogaerde A, Zanoli P, Puia G, Truzzi C, Kamuhabwa A, De Witte P, Merlevede W, Baraldi M (2000) Evidence that total extract of Hypericum perforatum affects exploratory behavior and exerts anxiolytic effects in rats. Pharmacol Biochem Behav 65:627–633 Vogt K, Mellor J, Tong G, Nicoll R (2000) The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron 26:187–196 Voikar V, Vasar E, Rauvala H (2004) Behavioral alterations induced by repeated testing in C57BL/6 J and 129S2/Sv mice: implications for phenotyping screens. Genes Brain Behav 3:27–38 Watanabe Y, Saito H, Abe K (1993) Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices. Neuropharmacology 32:479–486 Westbrook GL, Mayer ML (1987) Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons. Nature 328:640–643 White G, Lovinger DM, Peoples RW, Weight FF (1990) Inhibition of N-methyl-d-aspartate activated ion current by desmethylimipramine. Brain Res 537:337–339 Williams K (1996) Separating dual effects of zinc at recombinant N-methyl-d-aspartate receptors. Neurosci Lett 215:9–12 Wojcik J, Dudek D, Schlegel-Zawadzka M, Grabowska M, Marcinek A, Florek E, Piekoszewski W, Nowak RJ, Opoka W, Nowak G (2006) Antepartum/postpartum depressive symptoms and serum zinc and magnesium levels. Pharmacol Rep 58:571–576 Wonnemann M, Singer A, Muller WE (2000) Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John’s Wort: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology 23:188–197